Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Big4BioPhilly
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Big4BioPhilly
-
"What we are hypothesizing here is that there can be a third mechanism…that even in the presence of CD19 those leukemic cells are unable to die when they are triggered by CAR-T."
@Penn https://foundry.lbl.gov/2019/11/07/putting-the-heat-on-microbial-resistance-with-organic-polymers/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
We're seeking disruptive solutions to
#healthsecurity threats and together with@BARDA offering the right support at the right time to#DRIVeInnovation and protect Americans from health security threats. https://sciencecenter.org/discover/drive-accelerator-network …pic.twitter.com/58UafTbw3z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2019 has been a brilliant year for the Greater Philadelphia region! Learn why inside Big4Bio's Year-in-Review report for Philadelphia: https://big4bio.com/spotlights/spotlight-big4biophiladelphia-2019-year-in-review/ …pic.twitter.com/2B7vAzs4qV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
Proteins, fats, carbohydrates and the very building blocks of all living things – DNA – are all organic molecules. Check out how assistant professor John Milligan is using blue light to develop these molecules. https://fal.cn/36inJ
@ResearchAtJeff#LifeatJeffersonpic.twitter.com/5Pyw2JbTZF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lannett will announce financial results for its fiscal 2020 Q2 on February 5, 2020.
$LCIhttps://www.prnewswire.com/news-releases/lannett-to-report-fiscal-2020-second-quarter-financial-results-host-conference-call-on-wednesday-february-5-300995586.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Review the year that's been—grab a copy of the 2019 Year-in-Review report for the Greater Philadelphia region!
@PhillyBio@LifeSciencesPA https://big4bio.com/spotlights/spotlight-big4biophiladelphia-2019-year-in-review/ …pic.twitter.com/fvzBlrKksk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@templemedschool researchers found that an existing anticancer drug called SAHA helped animals with a condition known as heart failure with preserved ejection fraction. https://medicine.temple.edu/news/temple-led-research-team-finds-common-form-heart-failure-could-be-treated-already-approved …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Greater Philadelphia
#lifesciences community almost tripled its venture funding in 2019. Look through the just-released@Big4Bio Year-in-Review for Greater Philadelphia for key information on the news stories and deals from 2019! https://big4bio.com/spotlights/spotlight-big4biophiladelphia-2019-year-in-review/ …pic.twitter.com/q0Zxryx17Q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
"Next week, we will be meeting with some of our SPEARHEAD-1 investigators, as well as patient groups and other partners, during the
@myESMO#sarcoma & GIST symposium. Let us know if you would want to meet.#cancer#celltherapy"pic.twitter.com/3F6OvNGXRo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"This could allow clinicians to administer CAR T cell therapies in doses to target cancer cells without damaging as many healthy cells in the process, thus mitigating the side effects."
@PennEngineershttps://medium.com/penn-engineering/penn-nanoparticles-are-less-toxic-to-t-cells-engineered-for-cancer-immunotherapy-54a5d2de27eb …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
Cell And Gene Therapy Foresight In 2020: 7 Trends To Watch by Bruce Levine , PhD in "Cell & Gene"
@BLLPHDhttps://www.cellandgene.com/doc/cell-and-gene-therapy-foresight-in-trends-to-watch-0001 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Attend the 14th Annual Hub and SPP Model Optimization event, which will feature manufacturers, pharmacies, PBMs and more, on February 24-26, 2020, at the Loews Philadelphia Hotel. Register today!
@InformaConnect#conferencehttps://informaconnect.com/hub-and-spp-model-optimization/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
Start the year off right by registering for a table at the Life Sciences Pennsylvania 2020 Annual Dinner! Click and register today!http://ow.ly/PUUe50y7kmB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harmony will help commercialize its first drug WAKIX® (pitolisant) tablets, which was approved in August 2019, with the debt facility from OrbiMed.https://www.harmonybiosciences.com/newsroom/harmony-biosciences-secures-usd200-million-debt-facility-2/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
Our second Speaker Series event is this Thursday - January 30th! Featuring both Shahram Hejazi PhD, and Rick Jones MD, MBA as our speakers! Sign up here!
http://bit.ly/Speaker2020
Cant be there in person? Tune in to our live-stream! 
http://bit.ly/38JtIkA pic.twitter.com/z6zIY6TlTK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
Register by today to secure reduced rates on housing for the
@IAmBiotech CEO & Investor Conference on 2/10-2/11 in New York, NY!#debiomembers register with code BIOCEO1 and save up to $200! LEARN MORE: https://loom.ly/qEWRWns#netde#lifesciencepic.twitter.com/ncXT7ETCez
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Bruce is ideally suited to lead Passage Bio as chief executive officer given his strong neuroscience background coupled with his robust healthcare and biotechnology industry experience."
@Passage_Biohttps://www.biospace.com/article/releases/passage-bio-appoints-bruce-goldsmith-ph-d-as-chief-executive-officerco-founder-and-interim-ceo-stephen-squinto-ph-d-to-serve-as-acting-head-of-r-and-d-and-remain-on-board-of-directors/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Since news of Inovio's new source of funding for its development of a vaccine against the coronavirus from China, its shares have risen 26%.
#VirusCorona#vaccine#StockMarket#NASDAQ$INOhttps://www.bizjournals.com/philadelphia/news/2020/01/27/while-stock-markets-tumble-on-coronavirus-fears.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Philly proslijedio/la je Tweet
"Today's announcement should further increase investors' confidence that Skyrizi will not be part of the divestiture plan in the US."
$AZN$AGN$ABBVhttps://www.biopharmadive.com/news/abbvie-allergan-acquisition-skyrizi-astrazeneca/571122/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.